In older community-dwelling adults, common aging features were associated with FGF23, such as reduced eGFR and CKD, left ventricular hypertrophy, cardiac insufficiency, cardiovascular disease, increased fat mass, dyslipidemia and increased mortality.(20-24) In this study, patients with cardiovascular disease were excluded. The gene discussed is FGF23; the disease is metabolic syndrome.